c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Hibbert, Benjamin ^a   Chen, Yong Xiang ^a   O'Brien, Edward R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Cultured angiogenic cells; Endothelial progenitor cells; Stent

Indexed keywords

ALPHA ACTIN; STEM CELL FACTOR;

ADULT; AGED; ANGIOGRAPHY; ANTIBODY LABELING; ARTERY INTIMA; ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; CELL CULTURE; CELL LABELING; CONTROLLED STUDY; CORONARY ARTERY; CORONARY IN STENT RESTENOSIS; CORONARY STENT; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; RESTENOSIS; STEM CELL; TISSUE REPAIR; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACTINS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL COUNT; CELLS, CULTURED; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; HUMANS; IMMUNOLOGIC TECHNIQUES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELLS; STENTS;

EID: 3242739310     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00002.2004     Document Type: Article

References (33)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
2. Ashman PI, Jarboe DL, Conrad DH, and Huff TF. The mast cell-committed progenitor. In vitro generation of committed progenitor from bone marrow. J Immunol 146: 211-216, 1991.
3. Campbell JH, Han CL, and Campbell GR. Neointimal formation by circulating bone marrow cells. Ann NY Acad Sci 947: 18-24, 2001.
4. Chen YX and O'Brien ER. Ethylisopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing uPA activity. Can J Physiol Pharmacol 81: 730-739, 2003.
5. Froeschl M, Olsen S, Ma X, and O'Brien ER. Current understanding of in-stent restenosis and the potential benefit of drug eluting stents. Curr Drug Targets Cardiovasc Haematol Disord 4: 103-117, 2004.
6. George J, Herz I, Goldstein E, Abashidze S, Deutch V, Finkelstein A, Michowitz Y, Miller H, and Keren G. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 23: 57E-60E, 2003.
7. Glover C, Ma X, Chen YX, Miller H, Veinot J, Labinaz M, and O'Brien ER. Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation. Am Heart J 144: 702-709, 2002.
8. Glover C and O'Brien ER. Pathophysiological insights from studies of retrieved coronary atherectomy tissue. Semin Interv Cardiol 5: 167-173, 2000.
9. Grewe PH, Deneke T, Machraoui A, Barmeyer J, and Muller KP. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 35: 157-163, 2000.
10. Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, Mckenna RM, Stern E, and Rush DN. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 345: 93-97, 2002.
11. Hibbert B, Olsen S, and O'Brien ER. Involvement of progenitor cells in vascular repair. Trends Cardiovasc Med 13: 322-326, 2003.
12. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
13. Hristov M, Erl W, and Weber PC. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 13: 201-206, 2003.
14. Jiang X, Gurel O, Mendiaz EA, Stearns GW, Clogston CL, Lu HS, Osslund TD, Syed RS, Langley KE, and Hendrickson WA. Structure of the active core of human stem cell factor and analysis of binding to its receptor kit. EMBO J 19: 3192-3203, 2000.
15. Komatsu R, Ueda M, Naruko T, Kojima A, and Becker AE. Neointimal tissue response at sites of coronary stenting in humans. Macroscopic, histological, and immunohistochemical analyses. Circulation 98: 224-233, 1998.
16. 4-integrin subunit attenuates the acute inflammatory response to stent implantation yet is insufficient to prevent late intimal formation. J Leukoc Biol 75: 1016-1021.
17. Mayrhofer G, Gadd SJ, Spargo LD, and Ashman LK. Specificity of a mouse monoclonal antibody raised against acute myeloid leukemia cells for mast cells in human mucosal and connective tissue. Immunol Cell Biol 65: 241-250, 2003.
18. Mizgala HF, Gray LH, Ferris JA, Bociek V, Allard P, and Davies C. Coronary artery luminal narrowing in the young with sudden unexpected death: a coroner's autopsy study in 350 subjects age 40 years and under. Can J Cardiol 9: 33-40, 1993.
19. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, and Kim K. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 17: 433-439, 1991.
20. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, and Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue: implications for anti-proliferative therapy. Circ Res 73: 223-231, 1993.
21. O'Brien ER, Glover C, and Labinaz M. Initial experience with the Flexicut directional coronary atherectomy catheter for the treatment of coronary in-stent restenosis. J Invasive Cardiol 13: 618-622, 2001.
22. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, and Anversa P. Chimerism of the transplanted heart. N Engl J Med 346: 5-15, 2002.
23. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, and Taylor DA. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108: 457-463, 2003.
24. Rehman J, Li J, Orschell CM, and March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003.
25. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, and Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403-409, 2002.
26. Schwartz SM, deBlois D, and O'Brien ER. The intima: soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995.
27. Simper D, Stalboerger PG, Panetta CJ, Wang S, and Caplice NM. Smooth muscle progenitor cells in human blood. Circulation 106: 1199-1204, 2002.
28. Tjurmin AV, Ananyeva NM, Smith EP, Gao Y, Hong MK, Leon MB, and Haudenschild CC. Studies on the histogenesis of myxomatous tissue of human coronary lesions. Arterioscler Thromb Vasc Biol 19: 83-97, 1999.
29. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7, 2001.
30. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, and Isner JM. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105: 3017-3024, 2002.
31. Welt FG and Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 22: 1769-1776, 2002.
32. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, and Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: E17-E24, 2003.
33. Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER, Fisher DZ, and Fisher DE. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 14: 301-312, 2000.